World Yersinia Diagnostics Market - Opportunities and Forecasts, 2017 - 2023

  • ID: 3773018
  • Report
  • Region: Global
  • Allied Analytics LLP
1 of 2
Yersinia is a rod-shaped, gram positive bacterium in the Enterobacteriaceae family that causes enterocolitis, terminal iletis, mesenteric lymphadenitis, acute diarrhea and sepsis. The pathogen species of Yersinia include Yersinia pestis, Yersinia enterocolitica and Yersinia pseudotuberculosis. These species of Yersinia cause the Bubonic plague and gastroenteritis respectively. The symptoms of the diseases caused by these bacteria include gastroenteritis, vomiting, abdominal pain, low grade fever and diarrhea. The infection usually occurs in children. This infection affects men more often than women.

The treatment includes administration of cephalosporins, fluoroquinolones, tetracyclines, trimethoprim-sulfamethoxasole (TMP-SMZ) and aminoglycosides. There are several diagnostic tests that are performed to detect the infections, such as stool culture, ELISA, radioimmunoassay, tube agglutination, CT scan, ultrasonography, colonoscopy etc. Several techniques such as PCR utilize monoclonal antibodies to identify the infections. As per the geographic analysis, North America holds the dominant share in the Yersinia diagnostics market due to the rising incidence of the infections. The Asia Pacific region is the fastest growing region due to the presence of untapped opportunities and high prevalence of infection in countries like India and Japan. Abbott Laboratories, Gen-probe, Bio-Rad, Affymetrix Inc. are some of the major players in the Yersinia diagnostics market.

Key benefits

An in-depth analysis of various regions would provide a clear understanding of current and future trends so that companies can make region specific plans
Comprehensive analysis of the factors that drive and restrict the growth of the Yersinia diagnostics market is provided
Key regulatory guidelines of various regions which impact the Yersinia diagnostics market are critically examined
Quantitative analysis of the current market and estimations through 2013-2020 are provided to showcase the financial caliber of the market
Deep dive analysis of various regions provides insights that would enable companies to plan their business moves strategically
Value chain analysis in the report gives a clear understanding of the roles of the stakeholders involved in the supply chain of the Yersinia diagnostics market

Market Segmentation

The Yersinia diagnostics market is segmented based on test types, techniques and geography

By Test types

Stool Culture
ELISA
Radioimmunoassay
Tube Agglutination
CT Scan
Ultrasonography
Colonoscopy

By Techniques

PCR
DNA Probes
Monoclonal Antibodies
Immunoassay
IT
Others

By Geography

North America
Asia Pacific
Europe
LAMEA



* This report will be delivered in 12 Business Days. *
READ MORE
Note: Product cover images may vary from those shown
2 of 2

Loading
LOADING...

3 of 2
Note: Product cover images may vary from those shown
Adroll
adroll